Across TCGA pan-cancer cohorts, OR7E91P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated OR7E91P data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher OR7E91P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E91P expression acts as an unfavorable survival marker, although some lineages such as TGCT and ESCA show a favorable association.
SKCM, ACC, and KIRC are the cancer types where OR7E91P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.